A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure

Emmanuel Eroume Egom; Tiam Feridooni; Rebabonye B. Pharithi; Barkat Khan; Haaris A. Shiwani; Vincent Maher; Yassine El Hiani; Kishore B.S. Pasumarthi; Hilaire A. Ribama

doi:10.1016/j.biopha.2017.07.027

A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure

Emmanuel Eroume Egom, Tiam Feridooni, Rebabonye B. Pharithi, Barkat Khan, Haaris A. Shiwani, Vincent Maher, Yassine El Hiani, Kishore B.S. Pasumarthi, Hilaire A. Ribama

科研成果: 期刊稿件 › 文章 › 同行评审

10 引用（Scopus）

源语言	英语
页（从-至）	1144-1150
页数	7
期刊	Biomedicine and Pharmacotherapy
卷	93
DOI	https://doi.org/10.1016/j.biopha.2017.07.027
出版状态	已出版 - 9月 2017
已对外发布	是

!!!ASJC Scopus Subject Areas

药理学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.biopha.2017.07.027

其它文件与链接

指纹

探究 'A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure' 的科研主题。它们共同构成独一无二的指纹。

引用此

Egom, E. E., Feridooni, T., Pharithi, R. B., Khan, B., Shiwani, H. A., Maher, V., El Hiani, Y., Pasumarthi, K. B. S., & Ribama, H. A. (2017). A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomedicine and Pharmacotherapy, 93, 1144-1150. https://doi.org/10.1016/j.biopha.2017.07.027

A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. / Egom, Emmanuel Eroume; Feridooni, Tiam; Pharithi, Rebabonye B. 等.
在: Biomedicine and Pharmacotherapy, 卷 93, 09.2017, 页码 1144-1150.

科研成果: 期刊稿件 › 文章 › 同行评审

Egom, EE, Feridooni, T, Pharithi, RB, Khan, B, Shiwani, HA, Maher, V, El Hiani, Y, Pasumarthi, KBS & Ribama, HA 2017, 'A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure', Biomedicine and Pharmacotherapy, 卷 93, 页码 1144-1150. https://doi.org/10.1016/j.biopha.2017.07.027

Egom EE, Feridooni T, Pharithi RB, Khan B, Shiwani HA, Maher V 等. A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure. Biomedicine and Pharmacotherapy. 2017 9月;93:1144-1150. doi: 10.1016/j.biopha.2017.07.027

Egom, Emmanuel Eroume ; Feridooni, Tiam ; Pharithi, Rebabonye B. 等. / A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models : New hope for patients with pulmonary hypertension due to left ventricular heart failure. 在: Biomedicine and Pharmacotherapy. 2017 ; 卷 93. 页码 1144-1150.

@article{2eed6916d0d248e38d71dc28d6081d31,

title = "A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models: New hope for patients with pulmonary hypertension due to left ventricular heart failure",

author = "Egom, {Emmanuel Eroume} and Tiam Feridooni and Pharithi, {Rebabonye B.} and Barkat Khan and Shiwani, {Haaris A.} and Vincent Maher and {El Hiani}, Yassine and Pasumarthi, {Kishore B.S.} and Ribama, {Hilaire A.}",

note = "Funding Information: This study was sponsored by ECTRS Lt (Dartmouth, Canada) and Bonsai Horizons Lt (Dublin, Ireland) (EEE), Grant-in-aid from the Heart and Stroke Foundation of Canada (KP); NSHRF studentship (TF). Publisher Copyright: {\textcopyright} 2017 Elsevier Masson SAS",

year = "2017",

month = sep,

doi = "10.1016/j.biopha.2017.07.027",

language = "English",

volume = "93",

pages = "1144--1150",

journal = "Biomedicine and Pharmacotherapy",

issn = "0753-3322",

publisher = "Elsevier Masson",

}

TY - JOUR

T1 - A natriuretic peptides clearance receptor's agonist reduces pulmonary artery pressures and enhances cardiac performance in preclinical models

T2 - New hope for patients with pulmonary hypertension due to left ventricular heart failure

AU - Egom, Emmanuel Eroume

AU - Feridooni, Tiam

AU - Pharithi, Rebabonye B.

AU - Khan, Barkat

AU - Shiwani, Haaris A.

AU - Maher, Vincent

AU - El Hiani, Yassine

AU - Pasumarthi, Kishore B.S.

AU - Ribama, Hilaire A.

N1 - Funding Information: This study was sponsored by ECTRS Lt (Dartmouth, Canada) and Bonsai Horizons Lt (Dublin, Ireland) (EEE), Grant-in-aid from the Heart and Stroke Foundation of Canada (KP); NSHRF studentship (TF). Publisher Copyright: © 2017 Elsevier Masson SAS

PY - 2017/9

Y1 - 2017/9

UR - http://www.scopus.com/inward/record.url?scp=85024867681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024867681&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.07.027

DO - 10.1016/j.biopha.2017.07.027

M3 - Article

C2 - 28738523

AN - SCOPUS:85024867681

SN - 0753-3322

VL - 93

SP - 1144

EP - 1150

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

ER -